Companies / Natera, Inc.
Natera, Inc.
Financials · FY2025
Ownership
144.1M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 3.13% | 4,512,137 |
| 10%+ / strategic | 16.44% | 23,698,342 |
| Institutions | 75.46% | 108,766,206 |
| Public float | 4.97% | 7,167,485 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 14
View all →| Insider | % of shares | Shares |
|---|---|---|
Rabinowitz MatthewEXECUTIVE CHAIRMAN · Director | 1.60% | 2,312,772 |
Botha RoelofDirector | 0.75% | 1,080,783 |
Sheena JonathanDirector | 0.19% | 278,528 |
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | 0.16% | 233,285 |
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | 0.13% | 189,199 |
Chapman Steven LeonardCEOCEO AND PRESIDENT · Director | 0.11% | 156,607 |
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | 0.10% | 150,882 |
Brophy Michael BurkesCHIEF FINANCIAL OFFICER | 0.04% | 63,354 |
Baynes Roy D.Director | 0.01% | 18,429 |
Rosenman HermDirector | <0.01% | 5,927 |
Institutional holders 797
View all →| Holder | Value | % of shares |
|---|---|---|
| $2.96B | 7.57% | |
| $2.94B | 8.92% | |
| $2.82B | 8.54% | |
| $1.14B | 3.45% | |
| $992.32M | 2.54% | |
| $896.74M | 2.72% | |
| $580.64M | 1.76% | |
| $553.82M | 1.93% | |
| $508.34M | 1.76% | |
| $496.64M | 1.50% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Chapman Steven Leonard CEO | Sell | Common Stock | $16.89M | -72K -24.87% | 217,354 0.15% of shares | high |
| Feb 2, 2026 | Chapman Steven Leonard CEO | Sell | Common Stock | $9.63M | -42K -20.26% | 164,702 0.11% of shares | medium |
| Jan 21, 2026 | Brophy Michael Burkes Executive | Sell | Common Stock | $8.88M | -37K -36.32% | 64,123 0.04% of shares | medium |
| Jun 1, 2026 | Botha Roelof Director | Sell | Common Stock | $5.78M | -26K -2.29% | 1,127,787 0.78% of shares | medium |
| Jan 20, 2026 | Brophy Michael Burkes Executive | Sell | Common Stock | $5.62M | -24K -19.36% | 99,776 0.07% of shares | medium |
| Jan 20, 2026 | Moshkevich Solomon Executive | Sell | Common Stock | $5.45M | -23K -13.80% | 144,992 0.10% of shares | medium |
| Mar 16, 2026 | Rabinowitz Matthew Executive | Sell | Common Stock | $4.87M | -25K -1.05% | 2,327,483 1.61% of shares | medium |
| Jun 1, 2026 | Botha Roelof Director | Sell | Common Stock | $4.71M | -21K -1.91% | 1,096,383 0.76% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| JPMORGAN CHASE & CO | Passive13G/A | — |
| T. Rowe Price Associates, Inc. | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| NTRA | — | 632307104 |